RadNet unit DeepHealth wins FDA clearance for mammogram-based arterial calcification tool
PUBT · 06/25 10:01
Share
Listen to the news
- DeepHealth, a RadNet subsidiary, received two FDA 510(k) clearances expanding its AI breast imaging suite.
- Clearances cover automated breast arterial calcification assessment on mammograms, adding cardiovascular risk insights to routine screening.
- Also cleared prior-exam integration for ProFound Pro; the product will be marketed as Mammo Dx to help track lesions, improve detection, reduce recalls.
- Both functionalities are commercially available in the US; BAC Assessment is slated for deployment across RadNet imaging centers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RadNet Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250600PRIMZONEFULLFEED9752389) on June 25, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved